Omics: Technologies and Translations

From Physics to Daily Life: Applications in Biology, Medicine, and Healthcare

Volumn , Issue , 2014, Pages 121-152

  Kussmann, Martin ^a  

^a EPFL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84940668378     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527687077.ch06     Document Type: Chapter

References (156)

1. L. Hood, A personal view of molecular technology and how it has changed biology, Journal of Proteome Research, Volume 1, Issue 5, p. 399, 2002.
2. R. Aebersold, A mass spectrometric journey into protein and proteome research, Journal of the American Society for Mass Spectrometry, Volume 14, Issue 7, p. 685, 2003.
3. J.B. Fenn, Electrospray wings for molecular elephants (Nobel lecture), Angewandte Chemie International Edition in English, Volume 42, Issue 33, p. 3871, 2003.
4. K. Tanaka, The origin of macromolecule ionization by laser irradiation (Nobel lecture), Angewandte Chemie International Edition in English, Volume 42, Issue 33, p. 3860, 2003.
5. M. Karas and F. Hillenkamp, Laser desorption ionization of proteins with molecular masses exceeding 10 000 daltons, Analytical Chemistry, Volume 60, Issue 20, p. 2299, 1988.
6. V.E. Velculescu et al., Analysis of human transcriptomes, Nature Genetics, Volume 23, N. 4, p. 387, 1999.
7. J.C. Venter et al., The sequence ofthe human genome, Science, Volume 291, N. 5507, p. 1304, 2001.
8. J.H. Malone and B. Oliver, Microarrays, deep sequencing and the true measure of the transcriptome, BMC (BioMed Central) Biology, Volume 9, p. 34, 2011.
9. M. Schena et al., Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science, Volume 270, N. 5235, p. 467, 1995.
10. M. Kussmann et al., OMICS-driven biomarker discovery in nutrition and health, Journal of Biotechnology, Volume 124, N. 4, p. 758, 2006.
11. M. Kussmann et al., Profiling techniques in nutrition and health research, Current Opinion in Biotechnology, Volume 19, Issue 2, p. 83, 2008.
12. J.F. Hocquette, Where are we in genomics? Journal of Physiology and Pharmacology, Volume 56, Supplement 3, p. 37, 2005.
13. C.A. Heid et al., Real time quantitative PCR, Genome Research, Volume 6, N. 10, p. 986, 1996.
14. A. Giulietti et al., An overview of real-time quantitative PCR: applications to quantify cytokine gene expression, Methods, Volume 25, Issue 4, p. 386, 2001.
15. M. Kussmann et al., Profiling techniques in nutrition and health research, Current Opinion in Biotechnology, Volume 19, Issue 2, p. 83, 2008.
16. K. Kuhn et al., A novel, high-performance random array platform for quantitative gene expression profiling, Genome Research, Volume 14, N. 11, p. 2347, 2004.
17. T. Kai et al., The expression profile of purified Drosophila germline stem cells, Developmental Biology, Volume 283, Issue 2, p. 486, 2005.
18. E.T. Chan et al., Conservation of core gene expression in vertebrate tissues, Journal of Biology, Volume 8, p. 33, 2009.
19. P.T. Spellman et al., Comprehensive identification of cell cycle-regulated genes of the yeast Saccharomyces cerevisiae by microarray hybridization, Molecular Biology of the Cell, Volume 9, Issue 12, p. 3273, 1998.
20. T.R. Golub et al., Molecular classification of cancer: class discovery and class prediction by gene expression monitoring, Science, Volume 286, N. 5439, p. 531, 1999.
21. R.B. Brem et al., Genetic dissection of transcriptional regulation in buddingyeast, Science, Volume 296, N. 5568, p. 752, 2002.
22. Y. Zhang et al., Constraint and turnover in sex-biased gene expression in the genus Drosophila, Nature, Volume 450, N. 7167, p. 233, 2007.
23. J.H. Malone and B. Oliver, Microarrays, deep sequencing and the true measure of the transcriptome, BMC Biology, Volume 9, p. 34, 2011.
24. P.K. Tan et al., Evaluation of gene expression measurements from commercial microarray platforms, Nucleic Acids Research, Volume 31, N. 19, p. 5676, 2003.
25. L. Shi et al., The Micro Array Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements, Nature Biotechnology, Volume 24, N. 9, p. 1151, 2006.
26. M. Reimers, Making informed choices about microarray data analysis, PLOS (Public Library Of Science) Computational Biology, Volume 6, N. 5, p. e1 000 786, 2010.
27. X. Fan et al., Consistency of predictive signature genes and classifiers generated using different microarray platforms, Pharmacogenomics Journal, Volume 10, N. 4, p. 247, 2010.
28. V.E. Velculescu et al., Analysis of human transcriptomes, Nature Genetics, Volume 23, N. 4, p. 387, 1999.
29. S. Brenner et al., Gene expression analysis by massively parallel signature sequencing(MPSS) on microbead arrays, Nature Biotechnology, Volume 18, N. 6, p. 630, 2000.
30. J.G. Sutcliffe et al., TOGA: an automated parsingtechnology for analysing expression of nearly all genes, Proceedings of the National Academy of Sciences of the United States of America, Volume 97, N. 5, p. 1976, 2000.
31. S.Q. Ye et al., Gene expression profiling of human diseases by serial analysis of gene expression, Journal of Biomedical Science, Volume 9, N. 5, p. 384, 2002.
32. C. Colantuoni et al., High throughput analysis of gene expression in the human brain, Journal of Neurosciences Research, Volume 59, Issue 1, p. 1, 2000.
33. N.J. Beauchamp et al., Gene expression profiling of resting and activated vascular smooth muscle cells by serial analysis ofgene expression and clustering analysis, Genomics, Volume 82, Issue 3, p. 288, 2003.
34. M.D. Adams et al., The genome sequence of Drosophila melanogaster, Science, Volume 287, N. 5461, p. 2185, 2000.
35. E.R. Mardis, Next-generation DNA sequencing methods, Annual Review of Genomics and Human Genetics, Volume 9, p. 387, 2008.
36. Z. Wang et al., RNA-Seq: a revolutionary tool for transcriptomics, Nature Reviews Genetics, Volume 10, Issue 1, p. 57, 2009.
37. A. Mortazavi et al., Mapping and quantifying mammalian transcriptomes by RNA-Seq, Nature Methods, Volume 5, N. 7, p. 621, 2008.
38. M. Sultan et al., A global view of gene activity and alternative splicing by deep sequencing of the human transcriptome, Science, Volume 321, N. 5891, p. 956, 2008.
39. X. Fu et al., Estimating accuracy of RNA-Seq and microarrays with proteomics, BMC Genomics, Volume 10, p. 161, 2009.
40. J.C. Marioni et al., RNA-seq: an assessment of technical reproducibility and comparison with gene expression arrays, Genome Research, Volume 18, N. 9, p. 1509, 2008.
41. J.R. Bradford et al., A comparison of massively parallel nucleotide sequencing with oligonucleotide microarrays for global transcription profiling, BMC Genomics, Volume 11, p. 282, 2010.
42. Malone and B. Oliver, Microarrays, deep sequencing and the true measure of the transcriptome, BMC Biology, Volume 9, p. 34, 2011.
43. A. Agarwal et al., Comparison and calibration of transcriptome data from RNA-Seq and tiling arrays, BMC Genomics, Volume 11, p. 383, 2010.
44. C. Trapnell et al., Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation, Nature Biotechnology, Volume 28, N. 5, p. 511, 2010.
45. M. Telonis-Scott et al., Sex-specific splicing in Drosophila widespread occurrence, tissue specificity and evolutionary conservation, Genetics, Volume 181, N. 2, p. 421, 2009.
46. C. Trapnell et al., Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation, Nature Biotechnology, Volume 28, N. 5, p. 511, 2010.
47. J.H. Malone and B. Oliver, Microarrays, deep sequencingand the true measure of the transcriptome, BMC Biology, Volume 9, p. 34, 2011.
48. M.R. Wilkins et al., Progress with Proteome Projects: Why all Proteins Expressed by a Genome should be Identified, and How To Do It, Biotechnology and Genetic Engineering Reviews, Volume 13, N. 2, p. 19, 1996.
49. J.M. Lee et al., Proteomics and biomarkers in clinical trials for drug development, Journal of Proteomics, Volume 74, N. 12, p. 2632, 2011.
50. M. Kussmann, How to comprehensively analyse proteins and how this influences nutritional research, CCLM (Clinical Chemistry and Laboratory Medicine), Volume 45, Issue 3, p. 288, 2007.
51. M. Kussmann and M. Affolter, Proteomics at the centre of nutrigenomics: comprehensive molecular understanding of dietary health effects, Nutrition, Volume, 25, Issues 11-12, p. 1085, 2009.
52. M. Kussmann et al., Proteomics in nutrition and health, Combinatorial Chemistry and High Throughput Screening, Volume 8, N. 8, p. 679, 2005.
53. M. Kussmann et al., Proteomics in nutrition: status quo and Outlook for biomarkers and bioactives, Journal of Proteome Research, Volume 9, Issue 10, p. 4876, 2010.
54. R. Aebersold et al., Analysis and validation of proteomic data generated by tandem mass spectrometry, Nature Methods, Volume 4, N. 10, p. 787, 2007.
55. T. Kocher and G. Superti-Furga, Mass spectrometry-based functional proteomics: from molecular machines to protein networks, Nature Methods, Volume 4, N. 10, p. 807, 2007.
56. D.S. Cornett et al., MALDI imaging mass spectrometry: molecular snapshots of biochemical systems, Nature Methods, Volume, N. 4, p. 828, 2007.
57. N. Siuti and N.L. Kelleher, Decoding protein modifications using top-down mass spectrometry, Nature Methods, Volume 10, N. 4, p. 817, 2007.
58. L. Beretta, Proteomics from the clinical perspective: many hopes and much debate, Nature Methods, Volume 4, N. 10, p. 785, 2007.
59. D.N. Perkins et al., Probability-based protein identification by searching sequence databases using mass spectrometry data, Electrophoresis, Volume 20, Issue 18, p. 3551, 1999.
60. M.J. MacCoss et al., Probability-based validation of protein identifications using a modified SEQUEST algorithm, Analytical Chemistry, Volume 74, Issue 21, p. 5593, 2002.
61. C.A. Staab et al., Bioinformatics processing of protein and transcript profiles of normal and transformed cell lines indicates functional impairment of transcriptional regulators in buccal carcinoma, Journal of Proteome Research, Volume 6, Issue 9, p. 3705, 2007.
62. E. Holmes et al., Human metabolic phenotype diversity and its association with diet and blood pressure, Nature, Volume 453, N. 7193, p. 396, 2008.
63. S. Bajad and V. Shulaev, Highly-parallel metabolomics approaches usingLC-MS for pharmaceutical and environmental analysis, Trends in Analytical Chemistry, Volume 26, Issue 6, p. 625, 2007.
64. S.H. Zeisel et al., Highlights of the 2012 Research Workshop; Using Nutrigenomics and Metabolomics in Clinical Nutrition Research, Journal of Parenteral and Enteral Nutrition, Volume 37, N. 2, p. 190, 2012.
65. K.J. Field and J.A. Lake, Environmental metabolomics links genotype to phenotype and predicts genotype abundance in wild plant populations, Physiologia Plantarum, Volume 142, N. 4, p. 352, 2011.
66. M.M. Koek et al., Semi-automated non-target processingin GC x GC-MS metabolomics analysis: applicabilityfor biomedical studies, Metabolomics, Volume 7, Issue 1, p. 1, 2011.
67. M. Oresic, Metabolomics, a novel tool for studies of nutrition, metabolism and lipid dysfunction, Nutrition, Metabolism and Cardiovascular Diseases, Volume 19, Issue 11, p. 816, 2009.
68. S. Rezzi et al., Nutritional metabonomics: applications and perspectives, Journal of Proteome Research, Volume 6, Issue 2, p. 513, 2007.
69. M. Kussmann and P.J. Van Bladeren, The Extended Nutrigenomics - Understanding the Interplay between the Genomes of Food, Gut Microbes, and Human Host, Frontiers in Genetics, Volume 2, p. 21, 2011.
70. D.M. Jacobs et al., Non-digestible food ingredients, colonic microbiota and the impact on gut health and immunity: a role for metabolomics, Current Drug Metabolism, Volume 10, N. 1, p. 41, 2009.
71. A. Smolinska et al., NMR and pattern recognition methods in metabolomics: from data acquisition to biomarker discovery: a review, Analytica Chimica Acta, Volume 750, p. 82, 2012.
72. J.F. Xiao et al., Metabolite identification and quantitation in LC-MS/MS-based metabolomics, Trends in Analytical Chemistry, Volume 32, p. 1, 2012.
73. S. Becker et al., LC-MS-based metabolomics in the clinical laboratory, Journal of Chromatogra-phy B: Biomedical Sciences and Applications, Volume 883-884, p. 68, 2012.
74. J.L. Shuman et al., Plant metabolomics by GC-MS and differential analysis, Methods in Molecular Biology, Volume 678, p. 229, 2011.
75. I.R. Lanza et al., Quantitative metabolomics by H-NMR and LC-MS/MS confirms altered metabolic pathways in diabetes, PLOS One, Volume 5, Issue 5, e10538, 2010.
76. H.C. Keun and T.J. Athersuch, Nuclear magnetic resonance (NMR)-based metabolomics, Methods in Molecular Biology, Volume 708, p. 321, 2011.
77. V. Shulaev, Metabolomics technology and bioinformatics, Briefings in Bioinformatics, Volume 7, Issue 2, p. 128, 2006.
78. J.M. Lee et al., Flux balance analysis in the era of metabolomics, Briefings in Bioinformatics, Volume 7, Issue 2, p. 140, 2006.
79. L.B. Jorde and S.P. Wooding, Genetic variation, classification and 'race', Nature Genetics Supplement, Volume 36, N. 11, p. S28, 2004.
80. D.A. Hinds et al., Whole-genome patterns of common DNA variation in three human populations, Science, Volume 307, N. 5712, p. 1072, 2005.
81. J. Kaput, Nutrigenomics research for personalized nutrition and medicine, Current Opinion in Biotechnology, Volume 19, Issue 2, p. 110, 2008.
82. G.R. Abecasis et al., An integrated map of genetic variation from 1092 human genomes, Nature, Volume 491, N. 7422, p. 56, 2012.
83. E. Birney, The making of ENCODE: Lessons for big-data projects, Nature, Volume 489, N. 7414, p. 49, 2012.
84. E. Birney et al., Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project, Nature, Volume 447, N. 7146, p. 799, 2007.
85. I. Dunham et al., An integrated encyclopaedia of DNA elements in the human genome, Nature, Volume 489, N. 7414, p. 57, 2012.
86. A. Bensimon et al., Mass Spectrometry-Based Proteomics and Network Biology, Annual Review of Biochemistry, Volume 81, p. 379, 2012.
87. L.E. Hood et al., New and improved proteomics technologies for understanding complex biological systems: addressing a grand challenge in the life sciences, Proteomics, Volume 12, Issue 18, p. 2773, 2012.
88. K. Rose et al., Industrial-scale proteomics: from liters of plasma to chemically synthesized proteins, Proteomics, Volume 4, Issue 7, p. 2125, 2004.
89. P. Legrain et al., The human proteome project; current state and future direction, Molecular & Cellular Proteomics, Volume 10, Issue 7, p. 9993, 2011.
90. A.N. Hoofnagle et al., Painting a moving picture; large-scale proteomics efforts and their potential for changing patient care, Clinical Chemistry, Volume 57, N. 10, p. 1357, 2011.
91. Y.K. Paik et al., The Chromosome-Centric Human Proteome Project for cataloguing proteins encoded in the genome, Nature Biotechnology, Volume 30, Issue 3, p. 221, 2012.
92. R. Aebersold et al., The biology/disease-driven human proteome project (B/D-HPP): enabling protein research for the life sciences community, Journal of Proteome Research, Volume 12, Issue 1, p. 23, 2013.
93. A. Persson et al., A human protein atlas based on antibody proteomics, Current Opinion in Molecular Therapeutics, Volume 8, N. 3, p. 185, 2006.
94. L. Berglund et al., A genecentric Human Protein Atlas for expression profiles based on antibodies, Molecular & Cellular Proteomics, Volume 10, Issue 7, p. 2019, 2008.
95. L. Berglund et al., A genecentric Human Protein Atlas for expression profiles based on antibodies, Molecular & Cellular Proteomics, Volume 10, Issue 7, p. 2019, 2008.
96. D.S. Wishart et al., HMDB; the Human Metabolome Database, Nucleic Acids Research, Volume 35, Supplement 1, p. D521, 2007.
97. D.S. Wishart et al., HMDB 3.0 - The Human Metabolome Database in 2013, Nucleic Acids Research, Volume 41, Issue D1, p. 801, 2013.
98. S. Krug et al., The dynamic range of the human metabolome revealed by challenges, FASEB (Federation of American Societies for Experimental Biology) Journal, Volume 26, N. 6, p. 2607, 2012.
99. R. Dallmann et al., The human circadian metabolome, Proceedings of the National Academy of Sciences of the United States of America, Volume 109, N. 7, p. 2625, 2012.
100. V.R. Patel et al., CircadiOmics: integrating circadian genomics, transcriptomics, proteomics and metabolomics, Nature Methods, Volume 9, N. 8, p. 772, 2012.
101. J.K. Nicholson et al., The metabolome-wide association study: a new look at human disease risk factors, Journal of Proteome Research, Volume 7, Issue 9, p. 3637, 2008.
102. J.K. Nicholson, Global systems biology, personalized medicine and molecular epidemiology, Molecular Systems Biology, Volume 2, p. 52, 2006.
103. E. Holmes et al., Human metabolic phenotype diversity and its association with diet and blood pressure, Nature, Volume 453, Issue 7193, p. 396, 2008.
104. W. Bodmer and C. Bonilla, Common and rare variants in multifactorial susceptibility to common diseases, Nature Genetics, Volume 40, N. 6, p. 695, 2008.
105. J.K. Nicholson et al., The metabolome-wide association study: a new look at human disease risk factors, Journal of Proteome Research, Volume 7, Issue 9, p. 3637, 2008.
106. T.C. Matise et al., A 3.9-centimorgan-resolution human single-nucleotide polymorphism linkage map and screening set, The American Journal of Human Genetics, Volume 73, Issue 2, p. 271, 2003.
107. P.H. Sudmant et al., Diversity of human copy number variation and multicopy genes, Science, Volume 330, N. 6004, p. 641, 2010.
108. K.A. Frazer et al., A second generation human haplotype map of over 3.1 million SNPs, Nature, Volume 449, N. 7164, p. 851, 2007.
109. D. Gentilini et al., Role of epigenetics in human ageing and longevity; genome-wide DNA methylation profile in centenarians and centenarians' offspring, AGE, The Official Journal of the American Ageing Association, Volume 35, Issue 5, p. 1961, 2013.
110. A. Rada-Iglesias et al., Whole-genome maps ofUSF1 and USF2 binding and histone H3 acetylation reveal new aspects of promoter structure and candidate genes for common human disorders, Genome Research, Volume 18, N. 3, p. 380, 2008.
111. G.J. Hannon and J.J. Rossi, Unlocking the potential of the human genome with RNA interference, Nature, Volume 431, N. 7006, p. 371, 2004.
112. T.A. Manolio, Cohort studies and the genetics of complex disease, Nature Genetics, Volume 41, N. 1, p. 5, 2009.
113. W. Siffert, G protein polymorphisms in hypertension, atherosclerosis, and diabetes, Annual Review of Medicine, Volume 56, p. 17, 2005.
114. J.K. Nicholson et al., The metabolome-wide association study; a new look at human disease risk factors, Journal of Proteome Research, Volume 7, Issue 9, p. 3637, 2008.
115. A.R. Turner et al., Utility of genome-wide association study findings; prostate cancer as a translational research paradigm, Journal of Internal Medicine, Volume 271, Issue 4, p. 344, 2012.
116. V. Lyssenko et al., Clinical risk factors, DNA variants, and the development of type 2 diabetes, The New England Journal of Medicine, Volume 359, N. 21, p. 2220, 2008.
117. J.B. Meigs et al., Genotype score in addition to common risk factors for prediction of type 2 diabetes, The New England Journal of Medicine, Volume 359, N. 21, p. 2208, 2008.
118. L. Ronnegard and W. Valdar, Recent developments in statistical methods for detecting genetic loci affecting phenotypic variability, BMC Genetics, Volume 13, p. 63, 2012.
119. J.S. Beckmann et al., Copy number variants and genetic traits: closer to the resolution of phenotypic to genotypic variability, Nature Reviews Genetics, Volume 8, N. 8, p. 639, 2007.
120. S. Omori et al., Replication study for the association of new meta-analysis-derived risk loci with susceptibility to type 2 diabetes in 6244 Japanese individuals, Diabetologia, Volume 52, N. 8, p. 1554, 2009.
121. R.A. Myers et al., Further replication studies of the EVE Consortium meta-analysis identifies 2 asthma risk loci in European Americans, The Journal of Allergy and Clinical Immunology, Volume 130, Issue 6, p. 1294, 2012.
122. D.B. Goldstein, Common genetic variation and human traits, The New England Journal of Medicine, Volume 360, N. 17, p. 1696, 2009.
123. T.A. Manolio et al., Finding the missing heritability of complex diseases, Nature, Volume 461, N. 7265, p. 747, 2009.
124. M.I. McCarthy et al., Genome-wide association studies for complex traits: consensus, uncertainty and challenges, Nature Reviews Genetics, Volume 9, N. 5, p. 356, 2008.
125. A.C. Need and D.B. Goldstein, Whole genome association studies in complex diseases: where do we stand? Dialogues in Clinical Neuroscience, Volume 12, N. 1, p. 37, 2010.
126. M. Cargill and G.Q. Daley, Miningfor SNPs: puttingthe common variants--common disease hypothesis to the test, Pharmacogenomics, Volume 1, N. 1, p. 27, 2000.
127. S.K. Iyengar and R.C. Elston, The genetic basis of complex traits: rare variants or 'common gene, common disease?', Methods in Molecular Biology, Volume 376, p. 71, 2007.
128. J.N. Hirschhorn and M.J. Daly, Genome-wide association studies for common diseases and complex traits. Nature Reviews Genetics, Volume 6, N. 2, p. 95, 2005.
129. N. Blow, Genomics: the personal side of genomics, Nature, Volume 449, N. 7162, p. 627, 2007.
130. G. Jimenez-Sanchez et al., Human disease genes, Nature, Volume 409, N. 6822, p. 853, 2001.
131. T.J. McCorvie and D.J. Timson, Structural and molecular biology of type I galactosemia: disease-associated mutations, IUBMB (International Union of Biochemistry and Molecular Biology) Life, Volume 63, Issue 11, p. 949, 2011.
132. C.R. Scriver et al., The hyperphenylalaninemias of man and mouse, Annual Reviews of Genetics, Volume 28, p. 141, 1994.
133. J. Kaput and R.L. Rodriguez, Nutritional genomics: the next frontier in the postgenomic era, Physiological Genomics, Volume 16, N. 2, p. 166, 2004.
134. J.N. Hirschhorn et al., A comprehensive review of genetic association studies, Genetics in Medicine, Official Journal of the American College of Medical Genetics and Genomics, Volume 4, Issue 2, p. 45, 2002.
135. M.K Sakharkar and K.R. Sakharkar, Targetability of human disease genes, Current Drug Discovery Technologies, Volume 4, Issue 1, p. 48, 2007.
136. M.K. Sakharkar et al., Drugability of human disease genes, International Journal of Biochemistry & Cell Biology, Volume 39, Issue 6, p. 1156, 2007.
137. D.N. Cooper et al., Genes, mutations, and human inherited disease at the dawn of the age of personalized genomics, Human Mutation, Volume 31, Issue 6, p. 631, 2010.
138. F. Barrenas et al., Network properties of complex human disease genes identified through genomewide association studies, PLOS One, Volume 4, Issue 11, e8090, 2009.
139. X. Wu et al., Network-based global inference of human disease genes, Molecular Systems Biology, Volume 4, p. 189, 2008.
140. C.R. Scriver, The human genome project will not replace the physician, Canadian Medical Association Journal, Volume 171, N. 12, p. 1461, 2004.
141. R. Aebersold et al., The biology/disease-driven human proteome project (B/D-HPP); enabling protein research for the life sciences community, Journal of Proteome Research, Volume 12, Issue 1, p. 23, 2013.
142. N. Nagaraj et al., Deep proteome and transcriptome mapping ofa human cancer cell line, Molecular Systems Biology, Volume 7, p. 548, 2011.
143. M. Vidal et al., The human proteome - a scientific opportunity for transforming diagnostics, therapeutics, and healthcare, Clinical Proteomics, Volume 9, N. 1, p. 6, 2012.
144. A.M. Edwards, Too many roads not taken, Nature, Volume 470, N. 7333, p. 163, 2011.
145. R. Aebersold et al., The Biology/disease- driven Human proteome project (B/D-Hpp): enabling protein research for the Life Sciences community, Journal of Proteome Research, Volume 12, Issue 1, p. 23, 2013.
146. J. Lemoine et al., The current status of clinical proteomics and the use of MRM and MRM(3) for biomarker validation, Expert Review of Molecular Diagnostics, Volume 12, N. 4, p. 333, 2012.
147. A. Maiolica et al., Targeted proteome investigation via selected reaction monitoringmass spectrometry, Journal of Proteomics, Volume 75, Issue 12, p. 3495, 2012.
148. H. Mischak et al., Recommendations for biomarker identification and qualification in clinical proteomics, Science Translational Medicine, Volume 2, Issue 46, p. 46-48, 2010.
149. S. Lehmann et al., Quantitative Clinical Chemistry Proteomics (qCCP) using mass spectrometry: general characteristics and application, CCLM, Volume 51, Issue 5, p. 919, 2012.
150. K. Rose et al., Industrial-scale proteomics: from liters of plasma to chemically synthesized proteins, Proteomics, Volume 4, Issue 7, p. 2125, 2004.
151. R. Apweiler et al., Approaching clinical proteomics; current state and future fields of application in fluid proteomics, CCLM, Volume 47, Issue 6, p. 724, 2009.
152. R. Apweiler et al., Approaching clinical proteomics; current state and future fields of application in cellular proteomics, Cytometry Part A, Volume 75A, Issue 10, p. 816, 2009.
153. A.V. Edwards et al., The role of proteomics in clinical cardiovascular biomarker discovery, Molecular & Cellular Proteomics, Volume 7, Issue 10, p. 1824, 2008.
154. J. Kaput, Nutrigenomics research for personalized nutrition and medicine, Current Opinion in Biotechnology, Volume 19, Issue 2, p. 110, 2008.
155. M. Kussmann and L.B. Fay, Nutrigenomics and Personalized Nutrition - Science and Concept, Personalized Medicine, Volume 5, N. 5, p. 447, 2008.
156. S. Krug et al., The dynamic range of the human metabolome revealed by challenges, FASEB Journal, Volume 26, N. 6, p. 2607, 2012.